文献速递脑血管病

无症状颈动脉狭窄:颈动脉内膜切除术与初始药物治疗的比较效果

Comparative Effectiveness of Carotid Endarterectomy vs Initial Medical Therapy in Patients With Asymptomatic Carotid Stenosis.
PubMed 文献 · JAMA Neurol · 2020-01-01

该比较效果研究利用美国退伍军人事务部数据库,纳入65岁以上接受颈动脉影像的无症状颈动脉狭窄患者,构建初始药物治疗组和颈动脉内膜切除术组,随访5年。结果显示,颈动脉内膜切除术组5年致命和非致命卒中风险低于药物治疗组(5.6% vs 7.8%),但考虑非卒中死亡的竞争风险后差异无统计学意义(-0.8%)。

要点

  • 颈动脉内膜切除术组30天卒中或死亡率为2.5%。
  • 5年卒中风险绝对降低2.3%,但竞争风险分析后不显著。
  • 药物治疗可能是可接受的治疗策略。

核心结论

  • 早期颈动脉内膜切除术对致命和非致命卒中的绝对风险降低幅度不到20年前试验中风险差异的一半,且在考虑非卒中死亡竞争风险后不再有统计学意义。

研究设计与样本

  • 比较效果研究,使用美国退伍军人事务部数据库,纳入2005年至2009年接受颈动脉影像的65岁及以上退伍军人,构建初始药物治疗组和颈动脉内膜切除术组,随访5年,采用目标试验方法。

主要发现

  • 总样本5221例,颈动脉内膜切除术组2712例(51.9%),初始药物治疗组2509例(48.1%)。
  • 颈动脉内膜切除术组30天内卒中或死亡率为2.5%(95% CI, 2.0%-3.1%)。
  • 5年致命和非致命卒中风险:颈动脉内膜切除术组5.6% vs 初始药物治疗组7.8%,风险差异-2.3%(95% CI, -4.0% 至 -0.3%)。
  • 考虑非卒中死亡竞争风险后,风险差异为-0.8%(95% CI, -2.1% 至 0.5%),无统计学意义。
  • 符合随机对照试验纳入标准的患者中,5年卒中风险:颈动脉内膜切除术组5.5%(95% CI, 4.5%-6.5%) vs 初始药物治疗组7.6%(95% CI, 5.7%-9.5%),风险差异-2.1%(95% CI, -4.4% 至 -0.2%);竞争风险分析后风险差异-0.9%(95% CI, -2.9% 至 0.7%),无统计学意义。

临床怎么用

  • 鉴于不可忽视的围手术期30天风险及卒中预防的改善,对于无症状颈动脉狭窄患者,初始药物治疗可能是可接受的治疗策略。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

IMPORTANCE: Carotid endarterectomy (CEA) among asymptomatic patients involves a trade-off between a higher short-term perioperative risk in exchange for a lower long-term risk of stroke. The clinical benefit observed in randomized clinical trials (RCTs) may not extend to real-world practice. OBJECTIVE: To examine whether early intervention (CEA) was superior to initial medical therapy in real-world practice in preventing fatal and nonfatal strokes among patients with asymptomatic carotid stenosis. DESIGN, SETTING, AND PARTICIPANTS: This comparative effectiveness study was conducted from August 28, 2018, to March 2, 2020, using the Corporate Data Warehouse, Suicide Data Repository, and other databases of the US Department of Veterans Affairs. Data analyzed were those of veterans of the US Armed Forces aged 65 years or older who received carotid imaging between January 1, 2005, and December 31, 2009. Patients without a carotid imaging report, those with carotid stenosis of less than 50% or hemodynamically insignificant stenosis, and those with a history of stroke or transient ischemic attack in the 6 months before index imaging were excluded. A cohort of patients who received initial medical therapy and a cohort of similar patients who received CEA were constructed and followed up for 5 years. The target trial method was used to compute weighted Kaplan-Meier curves and estimate the risk of fatal and nonfatal strokes in each cohort in the pragmatic sample across 5 years of follow-up. This analysis was repeated after restricting the sample to patients who met RCT inclusion criteria. Cumulative incidence functions for fatal and nonfatal strokes were estimated, accounting for nonstroke deaths as competing risks in both the pragmatic and RCT-like samples. EXPOSURES: Receipt of CEA vs initial medical therapy. MAIN OUTCOMES AND MEASURES: Fatal and nonfatal strokes. RESULTS: Of the total 5221 patients, 2712 (51.9%; mean [SD] age, 73.6 [6.0] years; 2678 men [98.8%]) received CEA and 2509 (48.1%; mean [SD] age, 73.6 [6.0] years; 2479 men [98.8%]) received initial medical therapy within 1 year after the index carotid imaging. The observed rate of stroke or death (perioperative complications) within 30 days in the CEA cohort was 2.5% (95% CI, 2.0%-3.1%). The 5-year risk of fatal and nonfatal strokes was lower among patients randomized to CEA compared with patients randomized to initial medical therapy (5.6% vs 7.8%; risk difference, -2.3%; 95% CI, -4.0% to -0.3%). In an analysis that incorporated the competing risk of death, the risk difference between the 2 cohorts was lower and not statistically significant (risk difference, -0.8%; 95% CI, -2.1% to 0.5%). Among patients who met RCT inclusion criteria, the 5-year risk of fatal and nonfatal strokes was 5.5% (95% CI, 4.5%-6.5%) among patients randomized to CEA and was 7.6% (95% CI, 5.7%-9.5%) among those randomized to initial medical therapy (risk difference, -2.1%; 95% CI, -4.4% to -0.2%). Accounting for competing risks resulted in a risk difference of -0.9% (95% CI, -2.9% to 0.7%) that was not statistically significant. CONCLUSIONS AND RELEVANCE: This study found that the absolute reduction in the risk of fatal and nonfatal strokes associated with early CEA was less than half the risk difference in trials from 20 years ago and was no longer statistically significant when the competing risk of nonstroke deaths was accounted for in the analysis. Given the nonnegligible perioperative 30-day risks and the improvements in stroke prevention, medical therapy may be an acceptable therapeutic strategy.

来源:JAMA Neurol,查看原文。版权归原作者所有。

引用

  1. Keyhani S, Cheng EM, Hoggatt KJ, et al. Comparative Effectiveness of Carotid Endarterectomy vs Initial Medical Therapy in Patients With Asymptomatic Carotid Stenosis. JAMA Neurol. 2020. PMID: 32478802. doi:10.1001/jamaneurol.2020.1427

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。